CVS Group plc (LON:CVSG – Get Rating) insider Richard A. Connell bought 3,500 shares of the business’s stock in a transaction on Thursday, September 22nd. The shares were bought at an average cost of GBX 16 ($0.19) per share, for a total transaction of £560 ($676.66).
CVS Group Stock Performance
CVSG stock opened at GBX 1,659 ($20.05) on Friday. The stock has a 50-day moving average price of GBX 1,729.23 and a 200-day moving average price of GBX 1,711.01. CVS Group plc has a 1-year low of GBX 1,512 ($18.27) and a 1-year high of GBX 2,800 ($33.83). The company has a current ratio of 1.08, a quick ratio of 0.83 and a debt-to-equity ratio of 90.16. The firm has a market cap of £1.18 billion and a PE ratio of 4,477.78.
Wall Street Analysts Forecast Growth
Several research analysts have commented on CVSG shares. Royal Bank of Canada cut their target price on CVS Group from GBX 3,000 ($36.25) to GBX 2,200 ($26.58) and set an “outperform” rating on the stock in a report on Friday, May 27th. Berenberg Bank reissued a “buy” rating and issued a GBX 2,370 ($28.64) price objective on shares of CVS Group in a research report on Thursday.
About CVS Group
CVS Group plc engages in veterinary, pet crematoria, online pharmacy, and retail businesses. The company operates through four segments: Veterinary Practices, Laboratories, Crematoria, and Online Retail. It operates animal veterinary practices and complementary veterinary diagnostic businesses. The company also provides pet cremation and clinical waste services for veterinary practices.
- The Institutions Hold On To Darden Restaurants International
- What Steelcase’s Earnings Say About the Return to the Office?
- Is The Golden Age Of Homebuilding Already Over?
- These 3 Big Dividend Payers Also Boast Strong Price Growth
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
Receive News & Ratings for CVS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Group and related companies with MarketBeat.com's FREE daily email newsletter.